Nhale Inc. announced it is expanding its acquisition efforts toward the swelling medical marijuana space following the execution of a term sheet for $10 million in debt financing with Four Twenty Investments, Inc., a Toronto-based private investment group. The medical marijuana sector has experienced a surge in industry revenue thanks to favorable legislation toward growing and distributing cannabis for medical purposes. Furthermore, consumer trends in favor of legitimizing the use of alternative medical treatments have boosted the demand for these products.

Expected to top $2.3 billion this year, the U.S. market for medical cannabis is projected to exceed $10 billion by 2018, according to ArcView.

"As a highly regulated industry where licenses are constantly on the line, brands must establish strong protocols and skills. Nhale is poised to leverage its talent, resources and leadership to become a premier mover in the industry," said Lance Williams, President and CEO of Nhale. "With a growth rate of 38% since 2011, the medical marijuana market offers enormous opportunities for our highly experienced team to successfully collaborate with the sector's most robust start-ups."

Four Twenty Investments is focused on the financing and strategic investments of medical marijuana and similar companies involved in the cannabis industry. Nhale will utilize the proceeds of the financing to complete its intended acquisitions of revenue generating medical and recreational marijuana operations in states where it has been legalized.

Nhale is a U.S. company actively pursuing acquisition opportunities in the rapidly expanding marijuana industry. Nhale acquires companies with proven business models positioned to make a significant impact within the medical and recreational cannabis market. NHLE brings operating talent, tools and leadership to emerging companies in the space, promoting industry awareness and developing economically sustainable partnerships while increasing shareholder value.